Normal bone density obtained in the absence of insulin receptor expression in bone

Endocrinology

Volumn 147, Issue 12, 2006, Pages 5760-5767

  Irwin, Regina ^a   Lin, Hua V ^b   Motyl, Katherine J ^a   McCabe, Laura R ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN RECEPTOR; MESSENGER RNA; OSTEOCALCIN; PYRIDINOLINE; SOMATOMEDIN C; TRANSCRIPTION FACTOR RUNX2;

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE DEVELOPMENT; BONE MARROW; BRAIN; CELL COUNT; CELL CULTURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORTICAL BONE; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; KNOCKOUT MOUSE; LIVER; MOUSE; NONHUMAN; OBESITY; OSTEOBLAST; OSTEOLYSIS; PANCREAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STROMA CELL; TIBIA; TRANSGENE; WILD TYPE;

ADIPOCYTES, WHITE; ANIMALS; BONE AND BONES; BONE DENSITY; BONE MARROW; FATTY ACID-BINDING PROTEINS; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OSTEOCALCIN; RECEPTOR, IGF TYPE 1; RECEPTOR, INSULIN;

EID: 33751523583     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2006-0700     Document Type: Article

References (74)

1. Hui SL, Epstein S, Johnston Jr CC 1985 A prospective study of bone mass in patients with type I diabetes. J Clin Endocrinol Metab 60:74-80
2. Levin ME, Boisseau VC, Avioli LV 1976 Effects of diabetes mellitus on bone mass in juvenile and adult-onset diabetes. N Engl J Med 294:241-245
3. Piepkorn B, Kann P, Forst T, Andreas J, Pfutzner A, Beyer J 1997 Bone mineral density and bone metabolism in diabetes mellitus. Horm Metab Res 29:584-591
4. Kemink SA, Hermus AR, Swinkels LM, Lutterman JA, Smals AG 2000 Osteopenia in insulin-dependent diabetes mellitus: prevalence and aspects of pathophysiology. J Endocrinol Invest 23:295-303
5. Gunczler P, Lanes R, Paz-Martinez V, Martins R, Esaa S, Colmenares V, Weisinger JR 1998 Decreased lumbar spine bone mass and low bone turnover in children and adolescents with insulin dependent diabetes mellitus followed longitudinally. J Pediatr Endocrinol Metab 11:413-419
6. Buysschaert M, Cauwe F, Jamart J, Brichant C, De Coster P, Magnan A, Donckier J 1992 Proximal femur density in type 1 and 2 diabetic patients. Diabetes Metab 18:32-37
7. Tuominen JT, Impivaara O, Puukka P, Ronnemaa T 1999 Bone mineral density in patients with type 1 and type 2 diabetes. Diabetes Care 22:1196-1200
8. Hampson G, Evans C, Petitt RJ, Evans WD, Woodhead SJ, Peters JR, Ralston SH1998 Bone mineral density, collagen type 1 α1 genotypes and bone turnover in premenopausal women with diabetes mellitus. Diabetologia 41:1314-1320
9. Wiske PS, Wentworth SM, Norton Jr JA, Epstein S, Johnston Jr CC 1982 Evaluation of bone mass and growth in young diabetics. Metabolism 31:848-854
10. McNair P, Christiansen C, Christensen MS, Madsbad S, Faber OK, Binder C, Transbol I 1981 Development of bone mineral loss in insulin-treated diabetes: a 1 1/2 years follow-up study in sixty patients. Eur J Clin Invest 11:55-59
11. Auwerx J, Dequeker J, Bouillon R, Geusens P, Nijs J 1988 Mineral metabolism and bone mass at peripheral and axial skeleton in diabetes mellitus. Diabetes 37:8-12
12. Krakauer JC, McKenna MJ, Buderer NF, Rao DS, Whitehouse FW, Parfitt AM 1995 Bone loss and bone turnover in diabetes. Diabetes 44:775-782
13. Munoz-Torres M, Jodar E, Escobar-Jimenez F, Lopez-Ibarra PJ, Luna JD 1996 Bone mineral density measured by dual x-ray absorptiometry in Spanish patients with insulin-dependent diabetes mellitus. Calcif Tissue Int 58:316-319
14. Bouillon R, Bex M, Van Herck E, Laureys J, Dooms L, Lesaffre E, Ravussin E 1995 Influence of age, sex, and insulin on osteoblast function: osteoblast dysfunction in diabetes mellitus. J Clin Endocrinol Metab 80:1194-1202
15. Verhaeghe J, van Herck E, Visser WJ, Suiker AM, Thomasset M, Einhorn TA, Faierman E, Bouillon R 1990 Bone and mineral metabolism in BB rats with long-term diabetes. Decreased bone turnover and osteoporosis. Diabetes 39: 477-482
16. Herrero S, Calvo OM, Garcia-Moreno C, Martin E, San Roman JI, Martin M, Garcia-Talavera JR, Calvo JJ, del Pino-Montes J 1998 Low bone density with normal bone turnover in ovariectomized and streptozotocin-induced diabetic rats. Calcif Tissue Int 62:260-265
17. Verhaeghe J, Thomsen JS, van Bree R, van Herck E, Bouillon R, Mosekilde L 2000 Effects of exercise and disuse on bone remodeling, bone mass, and biomechanical competence in spontaneously diabetic female rats. Bone 27: 249-256
18. Shyng YC, Devlin H, Sloan P 2001 The effect of streptozotocin-induced experimental diabetes mellitus on calvarial defect healing and bone turnover in the rat. Int J Oral Maxillofac Surg 30:70-74
19. Botolin S, Faugere MC, Malluche H, Orth M, Meyer R, McCabe LR 2005 Increased bone adiposity and peroxisomal proliferator-activated receptor-γ2 expression in type I diabetic mice. Endocrinology 146:3622-3631
20. Thrailkill KM, Liu L, Wahl EC, Bunn RC, Perrien DS, Cockrell GE, Skinner RA, Hogue WR, Carver AA, Fowlkes JL, Aronson J, Lumpkin Jr CK 2005 Bone formation is impaired in a model of type 1 diabetes. Diabetes 54:2875-2881
21. Sasaki T, Kaneko H, Ramamurthy NS, Golub LM 1991 Tetracycline administration restores osteoblast structure and function during experimental diabetes. Anat Rec 231:25-34
22. McCracken M, Lemons JE, Rahemtulla F, Prince CW, Feldman D 2000 Bone response to titanium alloy implants placed in diabetic rats. Int J Oral Maxillofac Implants 15:345-354
23. Takeshita F, Iyama S, Ayukawa Y, Kido MA, Murai K, Suetsugu T 1997 The effects of diabetes on the interface between hydroxyapatite implants and bone in rat tibia. J Periodontol 68:180-185
24. Goodman WG, Hori MT 1984 Diminished bone formation in experimental diabetes. Relationship to osteoid maturation and mineralization. Diabetes 33:825-831
25. Nuttall ME, Gimble JM 2004 Controlling the balance between osteoblastogenesis and adipogenesis and the consequent therapeutic implications. Curr Opin Pharmacol 4:290-294
26. Gimble JM, Zvonic S, Floyd ZE, Kassem M, Nuttall ME 2006 Playing with bone and fat. J Cell Biochem 98:251-266
27. Verhaeghe J, Suiker AM, Visser WJ, Van Herck E, Van Bree R, Bouillon R 1992 The effects of systemic insulin, insulin-like growth factor-I and growth hormone on bone growth and turnover in spontaneously diabetic BB rats. J Endocrinol 134:485-492
28. Hough S, Avioli LV, Bergfeld MA, Fallon MD, Slatopolsky E, Teitelbaum SL 1981 Correction of abnormal bone and mineral metabolism in chronic streptozotocin-induced diabetes mellitus in the rat by insulin therapy. Endocrinology 108:2228-2234
29. Haffner SM, Bauer RL 1993 The association of obesity and glucose and insulin concentrations with bone density in premenopausal and postmenopausal women. Metabolism 42:735-738
30. Brownlee M, Vlassara H, Cerami A 1984 Nonenzymatic glycosylation and the pathogenesis of diabetic complications. Ann Intern Med 101:527-537
31. Horcajada-Molteni MN, Chanteranne B, Lebecque P, Davicco MJ, Coxam V, Young A, Barlet JP 2001 Amylin and bone metabolism in streptozotocin-induced diabetic rats. J Bone Miner Res 16:958-965
32. Clark RG 2004 Recombinant human insulin-like growth factor I (IGF-I): risks and benefits of normalizing blood IGF-I concentrations. Horm Res 62(Suppl 1):93-100
33. Yakar S, Kim H, Zhao H, Toyoshima Y, Pennisi P, Gavrilova O, Leroith D 2005 The growth hormone-insulin like growth factor axis revisited: lessons from IGF-1 and IGF-1 receptor gene targeting. Pediatr Nephrol 20:251-254
34. Okamoto H, Nakae J, Kitamura T, Park BC, Dragatsis I, Accili D 2004 Transgenic rescue of insulin receptor-deficient mice. J Clin Invest 114:214-223
35. Accili D, Drago J, Lee EJ, Johnson MD, Cool MH, Salvatore P, Asico LD, Jose PA, Taylor SI, Westphal H 1996 Early neonatal death in mice homozygous for a null allele of the insulin receptor gene. Nat Genet 12:106-109
36. Ontiveros C, McCabe LR 2003 Simulated microgravity suppresses osteoblast phenotype, Runx2 levels and AP-1 transactivation. J Cell Biochem 88:427-437
37. Ontiveros C, Irwin R, Wiseman RW, McCabe LR 2004 Hypoxia suppresses runx2 independent of modeled microgravity. J Cell Physiol 200:169-176
38. Li J, Takaishi K, Cook W, McCorkle SK, Unger RH 2003 Insig-1 "brakes" lipogenesis in adipocytes and inhibits differentiation of preadipocytes. Proc Natl Acad Sci USA 100:9476-9481
39. Kanazawa A, Tsukada S, Kamiyama M, Yanagimoto T, Nakajima M, Maeda S 2005 Wnt5b partially inhibits canonical Wnt/β-catenin signaling pathway and promotes adipogenesis in 3T3-L1 preadipocytes. Biochem Biophys Res Commun 330:505-510
40. Shefi-Friedman L, Wertheimer E, Shen S, Bak A, Accili D, Sampson SR 2001 Increased IGFR activity and glucose transport in cultured skeletal muscle from insulin receptor null mice. Am J Physiol Endocrinol Metab 281:E16-E24
41. Rosen CJ, Ackert-Bicknell CL, Adamo ML, Shultz KL, Rubin J, Donahue LR, Horton LG, Delahunty KM, Beamer WG, Sipos J, Clemmons D, Nelson T, Bouxsein ML, Horowitz M 2004 Congenic mice with low serum IGF-I have increased body fat, reduced bone mineral density, and an altered osteoblast differentiation program. Bone 35:1046-1058
42. Jiang J, Lichtler AC, Gronowicz GA, Adams DJ, Clark SH, Rosen CJ, Kream BE 2006 Transgenic mice with osteoblast-targeted insulin-like growth factor-I show increased bone remodeling. Bone 39:494-504
43. Niu T, Rosen CJ 2005 The insulin-like growth factor-I gene and osteoporosis: a critical appraisal. Gene 361:38-56
44. Nakae J, Kido Y, Accili D 2001 Distinct and overlapping functions of insulin and IGF-I receptors. Endocr Rev 22:818-835
45. Kream BE, Smith MD, Canalis E, Raisz LG 1985 Characterization of the effect of insulin on collagen synthesis in fetal rat bone. Endocrinology 116:296-302
46. Levy JR, Murray E, Manolagas S, Olefsky JM 1986 Demonstration of insulin receptors and modulation of alkaline phosphatase activity by insulin in rat osteoblastic cells. Endocrinology 119:1786-1792
47. Okamoto H, Obici S, Accili D, Rossetti L 2005 Restoration of liver insulin signaling in Insr knockout mice fails to normalize hepatic insulin action. J Clin Invest 115:1314-1322
48. Taniguchi CM, Emanuelli B, Kahn CR 2006 Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol 7:85-96
49. Wang Y, Sakata T, Elalieh HZ, Munson SJ, Burghardt A, Majumdar S, Halloran BP, Bikle DD 2006 Gender differences in the response of CD-1 mouse bone to parathyroid hormone: potential role of IGF-I. J Endocrinol 189:279-287
50. Gandhi A, Beam HA, O'Connor JP, Parsons JR, Lin SS 2005 The effects of local insulin delivery on diabetic fracture healing. Bone 37:482-490
51. Entingh-Pearsall A, Kahn CR 2004 Differential roles of the insulin and insulin-like growth factor-I (IGF-I) receptors in response to insulin and IGF-I. J Biol Chem 279:38016-38024
52. Zayzafoon M, Stell C, Irwin R, McCabe LR 2000 Extracellular glucose influences osteoblast differentiation and c-Jun expression. J Cell Biochem 79: 301-310
53. Zayzafoon M, Botolin S, McCabe LR 2002 P38 and activating transcription factor-2 involvement in osteoblast osmotic response to elevated extracellular glucose. J Biol Chem 277:37212-37218
54. Botolin S, McCabe LR 2006 Chronic hyperglycemia modulates osteoblast gene expression through osmotic and non-osmotic pathways. J Cell Biochem 99: 411-424
55. Balint E, Szabo P, Marshall CF, Sprague SM 2001 Glucose-induced inhibition of in vitro bone mineralization. Bone 28:21-28
56. Lalla E, Lamster IB, Feit M, Huang L, Spessot A, Qu W, Kislinger T, Lu Y, Stern DM, Schmidt AM 2000 Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice. J Clin Invest 105:1117-1124
57. Ding KH, Wang ZZ, Hamrick MW, Deng ZB, Zhou L, Kang B, Yan SL, She JX, Stern DM, Isales CM, Mi QS 2006 Disordered osteoclast formation in RAGE-deficient mouse establishes an essential role for RAGE in diabetes related bone loss. Biochem Biophys Res Commun 340:1091-1097
58. Kume S, Kato S, Yamagishi S, Inagaki Y, Ueda S, Arima N, Okawa T, Kojiro M, Nagata K 2005 Advanced glycation end-products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and bone. J Bone Miner Res 20:1647-1658
59. McCarthy AD, Etcheverry SB, Cortizo AM 2001 Effect of advanced glycation endproducts on the secretion of insulin-like growth factor-I and its binding proteins: role in osteoblast development. Acta Diabetol 38:113-122
60. Katayama Y, Akatsu T, Yamamoto M, Kugai N, Nagata N 1996 Role of nonenzymatic glycosylation of type I collagen in diabetic osteopenia. J Bone Miner Res 11:931-937
61. Inaba M, Nishizawa Y, Shioi A, Morii H 1997 Importance of sustained high glucose condition in the development of diabetic osteopenia: possible involvement of the polyol pathway. Osteoporos Int 7:S209-S212
62. Beamer WG, Donahue LR, Rosen CJ, Baylink DJ 1996 Genetic variability in adult bone density among inbred strains of mice. Bone 18:397-403
63. Beamer WG, Shultz KL, Donahue LR, Churchill GA, Sen S, Wergedal JR, Baylink DJ, Rosen CJ 2001 Quantitative trait loci for femoral and lumbar vertebral bone mineral density in C57BL/6J and C3H/HeJ inbred strains of mice. J Bone Miner Res 16:1195-1206
64. Judex S, Garman R, Squire M, Busa B, Donahue LR, Rubin C 2004 Genetically linked site-specificity of disuse osteoporosis. J Bone Miner Res 19:607-613
65. Kodama Y, Umemura Y, Nagasawa S, Beamer WG, Donahue LR, Rosen CR, Baylink DJ, Farley JR 2000 Exercise and mechanical loading increase periosteal bone formation and whole bone strength in C57BL/6J mice but not in C3H/Hej mice. Calcif Tissue Int 66:298-306
66. Rzonca SO, Suva LJ, Gaddy D, Montague DC, Lecka-Czernik B 2004 Bone is a target for the antidiabetic compound rosiglitazone. Endocrinology 145: 401-406
67. Lu H, Kraut D, Gerstenfeld LC, Graves DT 2003 Diabetes interferes with the bone formation by affecting the expression of transcription factors that regulate osteoblast differentiation. Endocrinology 144:346-352
68. He H, Liu R, Desta T, Leone C, Gerstenfeld LC, Graves DT 2004 Diabetes causes decreased osteoclastogenesis, reduced bone formation, and enhanced apoptosis of osteoblastic cells in bacteria stimulated bone loss. Endocrinology 145:447-452
69. Bouillon R 1991 Diabetic bone disease. Calcif Tissue Int 49:155-160
70. Accili D, Taylor SI 1991 Targeted inactivation of the insulin receptor gene in mouse 3T3-L1 fibroblasts via homologous recombination. Proc Natl Acad Sci USA 88:4708-4712
71. Cinti S, Eberbach S, Castellucci M, Accili D 1998 Lack of insulin receptors affects the formation of white adipose tissue in mice. A morphometric and ultrastructural analysis. Diabetologia 41:171-177
72. Diascro Jr DD, Vogel RL, Johnson TE, Witherup KM, Pitzenberger SM, Rutledge SJ, Prescott DJ, Rodan GA, Schmidt A 1998 High fatty acid content in rabbit serum is responsible for the differentiation of osteoblasts into adipocyte-like cells. J Bone Miner Res 13:96-106
73. Yokota T, Meka CS, Medina KL, Igarashi H, Comp PC, Takahashi M, Nishida M, Oritani K, Miyagawa J, Funahashi T, Tomiyama Y, Matsuzawa Y, Kincade PW 2002 Paracrine regulation of fat cell formation in bone marrow cultures via adiponectin and prostaglandins. J Clin Invest 109:1303-1310
74. Botolin S, McCabe LR 19 October 2006 Bone loss and increased adiposity in spontaneous and pharmacologically induced diabetic mice. Endocrinology 10.1210/en.2006-1006